AIZ vs URGN · P/E 15, rev $3.45B vs rev $109.8M
Assurant Inc (AIZ) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. URGN currently screens at market cap $1.61B.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. URGN currently screens at market cap $1.61B.
Not investment advice. Open the AIZ and URGN stock pages for the full models.
Not investment advice.